Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 19 June, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Laurus Labs Ltd

About the Company - Laurus Labs Ltd

Laurus Labs Ltd. is a Public Limited Listed company incorporated on 19/09/2005 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24239AP2005PLC047518 and registration number is 047518. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 4707.04 Cr. and Equity Capital is Rs. 107.47 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsLaurus Enclave, Plot Office 01, Edulapakabonangi Village, Vishakapatnam Andhra Pradesh 531021secretarial@lauruslabs.com
https://www.lauruslabs.com
Management
NamePosition Held
Dr. M Venu Gopala RaoNon Exe.Chairman&Ind.Director
Dr. C V Lakshmana RaoExecutive Director
Dr. Satyanarayana ChavaExecutive Director & CEO
Mr. V V Ravi KumarExecutive Director & CFO
Dr. Ravindranath KancherlaIndependent Director
Mrs. Aruna Rajendra BhingeIndependent Director
Dr. Rajesh Koshy ChandyIndependent Director
Mr. Chandrakanth ChereddiNon Executive Director

Basic Stock Data of Laurus Labs Ltd

Last Updated: June 17, 2024, 8:26 pm

Market Cap 23,440 Cr.
Current Price 435
High / Low471/328
Stock P/E105
Book Value 78.1
Dividend Yield0.46 %
ROCE7.48 %
ROE5.41 %
Face Value 2.00
PEG Ratio-19.66

Laurus Labs Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales1,2721,3991,2211,1769331,3781,4951,4981,5011,2791,1081,1581,132
Expenses8589368588427171,0051,0771,0721,1161,027980978962
Operating Profit415462363334215373418426385252128181170
OPM %33%33%30%28%23%27%28%28%26%20%12%16%15%
Other Income96847234367611
Interest17212521212928383941333838
Depreciation49515559606166767881848587
Profit before tax357396290258142285328317270137176357
Tax %25%26%23%24%23%22%29%28%26%25%24%26%25%
Net Profit267293222198109221232227199102134743
EPS in Rs4.985.464.143.682.034.124.314.233.701.900.240.870.79

Last Updated: June 11, 2024, 2:59 am

Laurus Labs Ltd Quarterly Chart

Laurus Labs Ltd Profit & Loss

Last Updated: June 1, 2024, 11:52 pm

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales4517191,1601,3261,7751,8922,0272,2362,7974,7694,7075,7734,677
Expenses3735739511,1211,4021,4781,6181,8842,2263,2583,4214,2923,946
Operating Profit781452092053724144093525711,5111,2861,482731
OPM %17%20%18%15%21%22%20%16%20%32%27%26%16%
Other Income159344322815526201629
Interest404164106111977586886696146150
Depreciation1823336186104121161184197235301337
Profit before tax2286121721802452411213041,2759751,051274
Tax %0%-2%20%-2%19%18%28%22%12%25%23%28%
Net Profit2288977414520017395267956750760205
EPS in Rs2.8311.5812.649.4718.363.783.271.785.0017.8213.9614.123.80
Dividend Payout %0%0%0%0%2%8%9%17%10%11%14%14%

Laurus Labs Ltd Profit & Loss Yearly Chart

Laurus Labs Ltd Growth

Compounded Sales Growth
10 Years:15%
5 Years:17%
3 Years:0%
TTM:-17%
Compounded Profit Growth
10 Years:9%
5 Years:19%
3 Years:-38%
TTM:-71%
Stock Price CAGR
10 Years:%
5 Years:46%
3 Years:-10%
1 Year:18%
Return on Equity
10 Years:18%
5 Years:20%
3 Years:16%
Last Year:5%

Last Updated: June 11, 2024, 6:55 pm

Laurus Labs Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital1515151616106106106107107107108108
Reserves911822816457901,2501,4071,4841,7092,6053,2813,9493,945
Preference Capital62626267670000000
Borrowings2252925438211,0158089471,0091,0511,4111,6531,7141,808
Other Liabilities1812124344114095095477188721,5021,5671,1871,461
Total Liabilities5137011,2731,8932,2292,6733,0083,3183,7395,6256,6096,9587,322
Fixed Assets1872364998011,0141,1931,4481,5991,6941,8182,1862,8843,001
CWIP32731161077014316310767324755357231
Investments000192651525858319362384432
Other Assets2943936589661,1191,2861,3451,5541,9203,1643,3063,3333,657
Total Assets5137011,2731,8932,2292,6733,0083,3183,7395,6256,6096,9587,322

Laurus Labs Ltd Reserves and Borrowings Chart

Laurus Labs Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 3988121-59197321369293345694823882
Cash from Investing Activity -46-124-312-406-315-282-417-257-217-900-837-735
Cash from Financing Activity 113420348690-4749-37-12724315-185
Net Cash Flow4-21221-27-80-00382-39

Laurus Labs Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days12080617891108100112102989894
Inventory Days136138165210177184199201233257279211
Days Payable1331171141019111010614415719414090
Cash Conversion Cycle123101112187177183193169177161237216
Working Capital Days1209348119117126124116119127140138
ROCE %17%27%25%15%17%17%14%8%14%38%23%22%

Laurus Labs Ltd Financial Efficiency Indicators Chart

Laurus Labs Ltd Share Holding Pattern

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Promoters28.76%27.45%27.30%27.30%27.27%27.27%27.27%27.27%27.20%27.20%27.20%27.20%
FIIs19.92%20.68%21.54%22.82%22.08%22.45%21.98%22.67%21.90%22.42%22.52%24.03%
DIIs4.08%3.56%4.15%4.81%6.90%7.93%9.11%9.34%9.51%9.74%10.36%11.01%
Public47.24%48.31%47.01%45.06%43.76%42.36%41.65%40.74%41.38%40.64%39.93%37.75%
No. of Shareholders2,12,5722,35,8362,99,2573,94,0534,67,4194,27,4654,07,1863,90,6954,23,9314,18,6154,17,9774,02,640

Laurus Labs Ltd Shareholding Pattern Chart

No. of Laurus Labs Ltd Shareholders

Laurus Labs Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Mirae Asset Midcap Fund4,110,0341.26148.681,589,9772024-06-17158.5%
Kotak Emerging Equity Fund - Regular Plan2,828,9620.3102.341,589,9772024-06-1777.92%
PGIM India Midcap Opportunities Fund2,530,0001.0191.521,589,9772024-06-1759.12%
Franklin India Prima Fund2,422,3581.0387.631,589,9772024-06-1752.35%
Sundaram Mid Cap Fund2,119,6990.976.681,589,9772024-06-1733.32%
Sundaram Mid Cap Fund - Institutional Plan2,119,6990.976.681,589,9772024-06-1733.32%
Bandhan Sterling Value Fund1,700,0000.9261.51,589,9772024-06-176.92%
Bandhan ELSS Tax Saver Fund1,600,0001.1557.881,589,9772024-06-170.63%
Axis Small Cap Fund1,589,9770.3557.521,589,9772024-06-170%
Franklin India Equity Advantage Fund1,100,0001.4339.791,589,9772024-06-17-30.82%

Laurus Labs Ltd ROCE Trend

Laurus Labs Ltd EPS Trend

Laurus Labs Ltd Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue2.002.002.002.0010.00
Basic EPS (Rs.)2.9814.6915.4218.3623.93
Diluted EPS (Rs.)2.9714.6415.4218.2823.93
Cash EPS (Rs.)10.2620.8120.1722.1641.39
Book Value[Excl.RevalReserv]/Share (Rs.)76.3675.1662.5148.47165.53
Book Value[Incl.RevalReserv]/Share (Rs.)76.3675.1662.5148.47165.53
Revenue From Operations / Share (Rs.)93.53112.1491.8589.70264.86
PBDIT / Share (Rs.)14.9129.6726.7229.3453.36
PBIT / Share (Rs.)7.7823.6522.0425.5235.84
PBT / Share (Rs.)4.3920.5920.1724.2527.46
Net Profit / Share (Rs.)3.1214.7915.4918.3323.88
NP After MI And SOA / Share (Rs.)2.9814.6715.4018.3323.88
PBDIT Margin (%)15.9426.4529.0932.7020.14
PBIT Margin (%)8.3121.0923.9928.4413.53
PBT Margin (%)4.6818.3521.9527.0310.36
Net Profit Margin (%)3.3313.1816.8620.439.01
NP After MI And SOA Margin (%)3.1813.0816.7620.439.01
Return on Networth / Equity (%)3.9019.5624.6937.8614.42
Return on Capital Employeed (%)7.9424.3727.6341.5718.62
Return On Assets (%)1.9110.3111.8717.106.80
Long Term Debt / Equity (X)0.190.180.170.160.09
Total Debt / Equity (X)0.600.480.510.500.53
Asset Turnover Ratio (%)0.620.820.761.020.79
Current Ratio (X)1.231.421.251.251.07
Quick Ratio (X)0.630.730.590.610.53
Inventory Turnover Ratio (X)1.371.511.401.952.04
Dividend Payout Ratio (NP) (%)0.0013.6010.377.6212.53
Dividend Payout Ratio (CP) (%)0.009.647.956.317.23
Earning Retention Ratio (%)0.0086.4089.6392.3887.47
Cash Earning Retention Ratio (%)0.0090.3692.0593.6992.77
Interest Coverage Ratio (X)4.399.6814.2623.106.37
Interest Coverage Ratio (Post Tax) (X)1.925.829.2715.433.85
Enterprise Value (Cr.)23483.3917717.0933370.2920697.574402.84
EV / Net Operating Revenue (X)4.662.936.764.301.55
EV / EBITDA (X)29.2111.0923.2413.157.72
MarketCap / Net Operating Revenue (X)4.192.616.424.041.22
Retention Ratios (%)0.0086.3989.6292.3787.46
Price / BV (X)5.143.919.467.481.95
Price / Net Operating Revenue (X)4.192.616.424.041.22
EarningsYield0.010.050.020.050.07

Laurus Labs Ltd Profitability Ratios (%)

Laurus Labs Ltd Liquidity Ratios

Laurus Labs Ltd Liquidity Ratios (%)

Laurus Labs Ltd Interest Coverage Ratios (%)

Laurus Labs Ltd Valuation Ratios

Fair Value

Fair Value: 445.69

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 2.46% compared to the current price 435

Intrinsic Value: 421.88

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Overvalued: 3.02% compared to the current price ₹435

Last 5 Year EPS CAGR: -5.34%

*Investments are subject to market risks

Strength and Weakness of Laurus Labs Ltd Stock

StrengthWeakness
  1. The stock has a high average ROCE of 19.75%, which is a positive sign.
  2. The company has higher reserves (1,663.00 cr) compared to borrowings (24.62 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (92.08 cr) and profit (203.31 cr) over the years.
  1. The stock has a high average Working Capital Days of 115.58, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 169.67, which may not be favorable.

FAQ

What is the latest fair value of Laurus Labs Ltd?

The latest fair value of Laurus Labs Ltd is ₹445.69.

What is the Market Cap of Laurus Labs Ltd?

The Market Cap of Laurus Labs Ltd is 23,440 Cr..

What is the current Stock Price of Laurus Labs Ltd as on 19 June 2024?

The current stock price of Laurus Labs Ltd as on 19 June 2024 is ₹435.

What is the High / Low of Laurus Labs Ltd stocks in FY 2024?

In FY 2024, the High / Low of Laurus Labs Ltd stocks is 471/328.

What is the Stock P/E of Laurus Labs Ltd?

The Stock P/E of Laurus Labs Ltd is 105.

What is the Book Value of Laurus Labs Ltd?

The Book Value of Laurus Labs Ltd is 78.1.

What is the Dividend Yield of Laurus Labs Ltd?

The Dividend Yield of Laurus Labs Ltd is 0.46 %.

What is the ROCE of Laurus Labs Ltd?

The ROCE of Laurus Labs Ltd is 7.48 %.

What is the ROE of Laurus Labs Ltd?

The ROE of Laurus Labs Ltd is 5.41 %.

What is the Face Value of Laurus Labs Ltd?

The Face Value of Laurus Labs Ltd is 2.00.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Laurus Labs Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE